The Sri Lankan government has decided to maintain a buffer stock of medicines to address the ongoing shortage in the country.
Deputy Health Minister Dr. Hansaka Wijayamuni said the move is in response to recurring issues such as tender cancellations and rejection of medicines after quality checks—key factors behind recent shortages.
The planned emergency stock is expected to cover the country’s medical needs for up to six months.
To ensure a stable supply, the government aims to directly import medicines through bilateral agreements with countries including India, Pakistan, Bangladesh, Malaysia, and the United States.
Dr. Wijayamuni added that maintaining this buffer stock would also help reduce the additional costs currently incurred from purchasing medicines on the open market. A cabinet paper will soon be presented to formalize and implement the initiative.
